PATENT CLAIM ANALYSIS

Application Number: 16018496
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "210210"]

Abstract:
The present inventions include a method of inhibiting COMT enzyme in a subject as well as compounds of formula I, or a pharmaceutically acceptable salt thereof, that are useful in the treatment of various disorders mediated by COMT, including Parkinson's disease and/or schizophrenia.

Claim (Index 7):
The method of  claim 1 , wherein Z is SO 2 R 1  and R 1  is selected from C 1 -C 10  alkyl, C 3 -C 10  cycloalkyl, phenyl, naphthyl, aralkyl, C-attached piperidinyl, C-attached 1H-benzimidazolyl, C-attached tetrahydro-2H-pyranyl and pyridinyl, any of which may be substituted with one or more groups selected from halogen, CF 3 , C 1 -C 4  alkyl, C 1 -C 4  alkoxy, C 3 -C 6  cycloalkyl, substituted or unsubstituted phenyl, substituted or unsubstituted pyridinyl, substituted or unsubstituted quinolinyl, substituted or unsubstituted 1H-indazolyl, substituted or unsubstituted aralkyl or acyl.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 94.0
- Lexical Diversity: 1.23077
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15011353', '15011365', '15458534', '11015348', '14097808']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8032018458633231
- 35 USC 102 Novelty (BERT): 0.5911071891973997
- Combined Prediction Score: 0.7819923801967308
- Mean Citation Score: 363.848216
- Max Citation Score: 524.0887
- Similarity Product: 410.0263567797602

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test